{"filings":[{"id":556957,"accession_number":"0001104659-26-064620","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-05-20T21:24:13+00:00","items":["5.02","1.01","5.07","7.01","9.01"],"status":"ready","headline":"Chiron appoints Charles Fitzgerald to board; declares Q2 preferred dividends","event_type":"leadership","confidence":"high","bullets":["Charles Fitzgerald appointed to Board effective May 20, 2026; serves on Compensation and Nominating Committees.","Fitzgerald holds 97,293 shares of common stock via affiliates (~$3.4M), aligning with shareholder interests.","Annual meeting results: all six director nominees elected; 2016 equity plan amendment approved (extend term to 2036, add 300,000 shares).","Q2 2026 preferred dividends: Series A $0.46875/share, Series B $0.50/share, payable July 31, 2026, record July 15."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93485,"accession_number":"0001104659-26-057976","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP","event_type":"other_material","confidence":"high","bullets":["Company enters $100M preferred equity purchase agreement with Maewyn XRN LP; initial closing of at least $25M by June 20, 2026.","Series C Preferred Stock carries 6% cumulative dividend, stepping to 8% after 4 years then +2% annually up to 12%.","Initial conversion price set at $43.00 per share of common stock (2.32558 shares per preferred share).","Maewyn receives board nomination and consent rights over debt, REIT status changes, and affiliate deals while holding >=5% of diluted common.","Proceeds to be used for general business and working capital, including potential acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93484,"accession_number":"0001104659-26-056346","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["1.01","2.02","7.01","8.01","9.01"],"status":"ready","headline":"Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%","event_type":"m_and_a","confidence":"high","bullets":["Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.","Secured $100M convertible preferred equity from Maewyn Capital Partners at 6.00%, initial conversion $43/share.","Q1 2026 core FFO $1.11/share (flat YoY), net loss $0.7M; same-property cash NOI up 3.2%.","Reduced monthly dividend from $0.25 to $0.16 (36% cut); new quarterly rate $0.48.","Withdrew 2026 earnings guidance citing portfolio transition; ~$200M asset sales under LOI at ~7% cash yield."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105147,"accession_number":"0001104659-26-027195","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-03-13T23:59:59+00:00","items":["1.01","5.03","8.01","9.01"],"status":"ready","headline":"Chiron Real Estate files for up to $75M Preferred ATM and updates Common ATM with $288M remaining","event_type":"other_material","confidence":"high","bullets":["Preferred ATM program launched for up to $75M of Series B Preferred Stock; agents get up to 2.0% commission.","Amended Common ATM: up to $288,010,090 in common stock still available; compensation up to 2.0%.","Articles Supplementary filed designating 3M additional Series B Preferred shares, total authorized 5.3M.","Partnership amended to authorize up to an additional 3M Series B Preferred Units (total 5.3M).","Common ATM adds Huntington Securities and Raymond James as sales agents and forward counterparties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105146,"accession_number":"0001104659-26-022515","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Chiron Real Estate enters $150M uncommitted senior note facility with NYL Investors","event_type":"debt","confidence":"high","bullets":["Master Note and Guaranty Agreement with NYL Investors LLC establishes uncommitted facility for up to $150M aggregate principal.","Notes are senior unsecured obligations of Chiron Real Estate LP, maturing up to 10 years; minimum issuance $10M.","Interest rates set at issuance based on spreads over U.S. Treasury securities; no obligation for NYL to purchase notes.","Parent Chiron Real Estate Inc. and subsidiary guarantors provide unconditional guarantees.","Facility available for three years from March 2, 2026; proceeds for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105145,"accession_number":"0001104659-26-019760","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","5.03","7.01","8.01","9.01"],"status":"ready","headline":"Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).","Q4 Core FFO $1.16/sh, up 6.4% YoY; same-property Cash NOI growth 5.4% YoY.","Full year 2026 Core FFO guidance $4.30-$4.45 per share; no debt maturities in 2026/27.","Dividend switched from quarterly to monthly at $0.25/sh ($3.00 annualized, unchanged); White Rock Medical tenant filed Chapter 11.","Completed $51.3M Series B preferred offering; company renamed from Global Medical REIT to Chiron (XRN)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":148208000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105148,"accession_number":"0001104659-26-006609","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2026-01-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Henry Cole to step down at 2026 Annual Meeting","event_type":"leadership","confidence":"high","bullets":["Henry Cole notified Board he will leave as director effective at 2026 Annual Meeting.","Cole will not be nominated for re-election; term expires at Annual Meeting.","Departure is not due to any disagreement with the Company on operations or policies.","No replacement director has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121402,"accession_number":"0001104659-25-118474","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ronald Marston to retire at 2026 annual meeting","event_type":"leadership","confidence":"high","bullets":["Ronald Marston notified board on December 3, 2025 of intent to retire as director.","Retirement effective at the 2026 Annual Meeting of Stockholders; he will not be nominated for reelection.","No replacement announced; board will fill vacancy in due course.","Marston's decision not due to any disagreement with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121401,"accession_number":"0001104659-25-113664","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["1.01","3.03","5.03","9.01"],"status":"ready","headline":"Global Medical REIT to issue 2M shares of 8.00% Series B Preferred Stock at $25/share","event_type":"debt","confidence":"high","bullets":["Offering of 2,000,000 shares (plus 300,000 over-allotment) of 8.00% Series B cumulative redeemable preferred stock at $25.00 per share.","Expected to close November 20, 2025; net proceeds will be contributed to the operating partnership for Series B Preferred Units.","Series B Preferred Stock ranks senior to common stock and on parity with existing Series A Preferred Stock; dividend of 8.00% per annum.","Articles Supplementary filed November 18, 2025 with Maryland State Department of Assessments and Taxation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121400,"accession_number":"0001104659-25-110921","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Global Medical REIT Q3 2025 net loss of $6.0M vs income $1.8M YoY; occupancy 95.2%","event_type":"earnings","confidence":"high","bullets":["Net loss $6.0M ($0.45/diluted share) vs net income $1.8M ($0.14) in Q3 2024.","Portfolio 95.2% occupied, 5.2M leasable sq ft, annualized base rent $118.4M.","Same-store cash NOI growth 2.7% YoY; Net Debt/Annualized Adjusted EBITDAre 6.9x.","Weighted average lease term 5.3 years; 72% outpatient medical buildings, 25% inpatient facilities.","Q3 2025 net loss included $6.3M impairment on investment property."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":109816000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121399,"accession_number":"0001104659-25-106390","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q3 net loss $6.0M vs income $1.8M; FFO/AFFO up 4%; narrows 2025 AFFO guidance","event_type":"earnings","confidence":"high","bullets":["Net loss $6.0M ($0.45/diluted) vs net income $1.8M ($0.14); includes $6.3M impairment on sold Aurora, IL property.","FFO $14.5M ($1.00/shr+unit) and AFFO $16.2M ($1.12) are each up 4% year-over-year on a per-share basis.","Same-store cash NOI growth 2.7% YoY; leased occupancy 95.2% at Sept 30; rental revenue $37.0M, up 8.4%.","Completed 1-for-5 reverse stock split; established $50M buyback (none executed); amended credit facility extending maturities through 2029-2031.","Narrowed 2025 AFFO guidance to $4.50-$4.60 per share/unit from $4.45-$4.65."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":109816000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121398,"accession_number":"0001104659-25-097935","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Global Medical REIT amends credit facility, extends maturities to 2029-2031, enters $350M hedges","event_type":"debt","confidence":"high","bullets":["$400M revolver maturity extended to Oct 2029 with two six-month extension options to Oct 2030.","$350M Term Loan A split into three tranches: $100M to Oct 2029, $100M to Oct 2030, $150M to Apr 2031.","Removed 10 bps SOFR credit spread adjustment on all facility borrowings.","Entered $350M forward starting interest rate swaps at fixed base rates 3.24%-3.32%, all-in effective rates 4.75%-4.84%.","Weighted average debt term increased from 1.3 years to 4.4 years at closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138054,"accession_number":"0001104659-25-091732","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-09-19T23:59:59+00:00","items":["3.03","5.03","7.01","8.01","9.01"],"status":"ready","headline":"Global Medical REIT completes 1:5 reverse stock split; shares to trade on NYSE Sept 22","event_type":"other_material","confidence":"high","bullets":["Effective Sept 19, 2025, every five shares of common stock converted into one; par value remains $0.001.","Authorized shares reduced from 500M to 100M; outstanding shares cut from 67,037,048 to ~13,407,409.","No fractional shares issued; stockholders receive cash in lieu based on Sept 19 closing price.","Corresponding adjustments made to equity plan shares, outstanding awards, repurchase program, and operating partnership units.","Common stock trades under same symbol GMRE with new CUSIP 37954A303 starting Sept 22."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138053,"accession_number":"0001104659-25-074239","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Global Medical REIT Q2 net loss narrows to $0.8M; appoints Mark Decker Jr. CEO; reaffirms AFFO guidance","event_type":"earnings","confidence":"high","bullets":["Net loss narrowed to $0.8M ($0.01/diluted share) from $3.1M loss YoY; FFO $0.20/share, AFFO $0.23/share.","Revenue $37.9M (+10.7% YoY); portfolio 94.5% occupied, 5.2M sq ft, annualized base rent $117.5M.","Acquired $69.6M five-property medical portfolio at 9.0% cap rate with $6.3M annualized base rent.","Appointed Mark Decker Jr. as CEO, President, and Board member effective June 2025.","Reaffirmed FY2025 AFFO guidance of $0.89-$0.93 per share; declared $0.15/share common dividend."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":72587000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155464,"accession_number":"0001104659-25-061389","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-06-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GMRE appoints Mark Decker as CEO; Jeffrey Busch becomes non-executive Chairman","event_type":"leadership","confidence":"high","bullets":["Mark O. Decker, Jr. appointed CEO and President effective June 23, 2025; also joins Board.","Jeffrey M. Busch removed as CEO and President; continues as non-executive Chairman.","Decker's base salary $700k; target annual bonus at 100% of base; initial LTIP award $1M.","Decker previously CEO of Centerspace (NYSE:CSR) and co-led net lease strategy at Proterra.","Relocation assistance of $75k provided; severance includes 2x salary+bonus on qualifying termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155463,"accession_number":"0001104659-25-053594","cik":1533615,"company_name":"Chiron Real Estate Inc.","ticker":"XRN","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Global Medical REIT cuts quarterly common dividend from $0.21 to $0.15 per share","event_type":"dividend","confidence":"high","bullets":["Board declared Q2 2025 common dividend of $0.15/share, down from $0.21; payable July 9 to holders of record June 20.","Dividend reduction expected to retain over $17M annually, strengthening balance sheet and funding future growth.","YTD 2025: $69.6M in acquisitions (5 properties) at 9.0% cap rate; $8.2M dispositions with $1.4M gain.","Beaumont, TX facility re-leased to CHRISTUS Health for 15 years at $2.9M annual rent, replacing bankrupt Steward Health.","Series A Preferred dividend maintained at $0.46875/share, payable July 31."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}